Publicacións en colaboración con investigadores/as de Université de Genève (13)

2024

  1. Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings

    Psychiatry and Clinical Neurosciences

2020

  1. Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions

    Journal of Endocrinology, Vol. 240, Núm. 3, pp. 483-496

2016

  1. Sequence variation between 462 human individuals fine-tunes functional sites of RNA processing

    Scientific Reports, Vol. 6

2015

  1. Structure-Based Design and Optimization of Multitarget-Directed 2 H -Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases

    Journal of Medicinal Chemistry, Vol. 58, Núm. 14, pp. 5561-5578

2014

  1. Pneumococcal vaccination in Europe: Schedule adherence

    Clinical Therapeutics, Vol. 36, Núm. 5

2013

  1. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: A retrospective study

    Pediatrics, Vol. 131, Núm. 6

  2. Transcriptome and genome sequencing uncovers functional variation in humans

    Nature, Vol. 501, Núm. 7468, pp. 506-511

2012

  1. RNA/DNA co-analysis from blood stains - Results of a second collaborative EDNAP exercise

    Forensic Science International: Genetics, Vol. 6, Núm. 1, pp. 70-80

  2. Reconstructing Native American population history

    Nature, Vol. 488, Núm. 7411, pp. 370-374

2011

  1. Distinguishing the relevant features of frequent suicide attempters

    Journal of Psychiatric Research, Vol. 45, Núm. 5, pp. 619-625

2009

  1. Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity

    Journal of Neuroscience, Vol. 29, Núm. 18, pp. 5916-5925

  2. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: Development and biopharmacological profiling of 7-[(3-chlorobenzyl) oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor

    Journal of Medicinal Chemistry, Vol. 52, Núm. 21, pp. 6685-6706